APA (7th ed.) Citation

Korman, N. J., Warren, R. B., Bagel, J., Armstrong, A. W., Gooderham, M., Strober, B., . . . Blauvelt, A. (2024). Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. Journal of Dermatological Treatment, 35(1), 1. https://doi.org/10.1080/09546634.2024.2371045

Chicago Style (17th ed.) Citation

Korman, Neil J., et al. "Deucravacitinib Onset of Action and Maintenance of Response in Phase 3 Plaque Psoriasis Trials." Journal of Dermatological Treatment 35, no. 1 (2024): 1. https://doi.org/10.1080/09546634.2024.2371045.

MLA (9th ed.) Citation

Korman, Neil J., et al. "Deucravacitinib Onset of Action and Maintenance of Response in Phase 3 Plaque Psoriasis Trials." Journal of Dermatological Treatment, vol. 35, no. 1, 2024, p. 1, https://doi.org/10.1080/09546634.2024.2371045.